Cover Image

A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine

Saved in:

Bibliographic Details
Main Authors:	Kristen Lospinoso, BS (Author), Cameron S. Nichols, MD (Author), Stephen J. Malachowski, MD (Author), Mark C. Mochel, MD (Author), Fnu Nutan, MD (Author)
Format:	Book
Published:	Elsevier, 2021-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reply to "Widespread Cutaneous Reaction to the Johnson & Johnson Ad26.Cov2.S Vaccine"
by: Stephen J. Malachowski, MD, et al.
Published: (2022)

Cutaneous small vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination
by: Corbett T. Berry, MD, PhD, et al.
Published: (2021)

Response to Berry et al's "Cutaneous small-vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination"
by: Natalie H. Matthews, MD, MPhil, et al.
Published: (2022)

Widespread cutaneous reaction to the Johnson & Johnson Ad26.COV2.S vaccine
by: Josiah Sowell, BS, et al.
Published: (2022)

Reacción dérmica local retardada a la vacuna Ad26.CoV2. de Janssen
by: Luis G. Domínguez-Carrillo, et al.
Published: (2022)

Widespread annular eruption after Ad26.COV2.S COVID-19 vaccine
by: Eingun James Song, MD, et al.
Published: (2021)

Role of bone scan in diagnosis of calciphylaxis: A review
by: Morgan Groover, BS, et al.
Published: (2024)

A Severe Case of Cutaneous Adverse Drug Reaction Secondary to a Novice Drug: Idelalisib
by: Joseph Gabriel Gabriel MD, et al.
Published: (2017)

Identification of cutaneous immune-related adverse events by International Classification of Diseases codes and medication administration
by: Wenxin Chen, BS, et al.
Published: (2022)

Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect
by: Leore Lavin, MSc, et al.
Published: (2024)

Acceleration of cutaneous T-cell lymphoma following dupilumab administration
by: Kristen Russomanno, MD, et al.
Published: (2021)

Unusual Route of Buprenorphine Administration: An Alternative Approach for Bypassing Adverse Drug Reactions
by: Azadeh Nazari, MD, Ph.D, et al.
Published: (2019)

Nivolumab-Induced de novo Discoid Lupus Erythematosus
by: Jaya Manjunath, et al.
Published: (2022)

Adverse cutaneous drug reaction
by: Nayak Surajit, et al.
Published: (2008)

Avapritinib-induced photo-aggravated cutaneous reaction
by: Farinoosh Dadrass, MS, et al.
Published: (2022)

Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathology
by: Shara Chopra, BS, BA, et al.
Published: (2021)

Severe Cutaneous Adverse Drug Reaction
by: Damayanti Damayanti, et al.
Published: (2017)

Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study
by: Ahmad Shahin, BS, et al.
Published: (2023)

Id reaction following the treatment of a cutaneous larva migrans
by: Pascal del Giudice, MD, et al.
Published: (2023)

Cutaneous reactions with enfortumab vedotin: A case series and review of the literature
by: Allison S. Dobry, MD, et al.
Published: (2021)

Patients with severe cutaneous adverse drug reactions have extremely high hair cortisol concentrations that do not correlate with the presence of depression
by: Eddy M. Zitha, MSc, MD, et al.
Published: (2024)

Sarcoma-associated lichen planus-like paraneoplastic autoimmune multiorgan syndrome with colonic perforation
by: Fnu Nutan, MD, et al.
Published: (2021)

Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS
by: Ming-Ming Yan, et al.
Published: (2022)

Cold panniculitis: Adverse cutaneous effect of whole-body cryotherapy
by: Elizabeth Greenwald, BA, et al.
Published: (2018)

Pharmacovigilance of Severe Cutaneous Adverse Drug Reactions
by: Kriteeka Saini, et al.
Published: (2022)

Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
by: Gabriela Rossi, et al.
Published: (2021)

Unusual and interesting adverse cutaneous drug reactions
by: Vaishali Masatkar, et al.
Published: (2018)

Controversies in the management of cutaneous adverse drug reactions
by: Yashpal Manchanda, et al.
Published: (2018)

Skin Test for Cutaneous Adverse Drug Reactions
by: Yusuf Wibisono, et al.
Published: (2020)

Adverse cutaneous reactions induced by exposure to woods
by: Dorota Chomiczewska-Skóra
Published: (2013)

Cutaneous hypersensitivity reaction with acute hepatitis following COVID-19 vaccine
by: Christine Y. Wong, MD, et al.
Published: (2021)

Serum sickness-like reaction following an administration of the first dose of inactivated COVID19 vaccine
by: Sasipim Chaijaras, MD, et al.
Published: (2022)

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
by: Catherine Riou, et al.
Published: (2024)

Recent advances in severe cutaneous adverse drug reaction
by: Sudip Das, et al.
Published: (2018)

An Update on Adverse Cutaneous Drug Reactions in HIV/AIDS
by: Koraisha Hoosen, et al.
Published: (2019)

Cutaneous reaction reported after third Moderna COVID-19 vaccine
by: Sophie H. Guénin, MSc, et al.
Published: (2021)

A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology
by: G. Alden Holmes, MD, et al.
Published: (2021)

Sudden-onset painful eruption of the hands: A cutaneous chimeric antigen receptor T-cell therapy reaction
by: Jimena A. Miranda, MD, et al.
Published: (2023)

Parental Experience of Potential Adverse Drug Reactions Related to Their Oral Administration of Antipyretic Analgesic Medicines in Children in Saudi Arabia
by: Mansour Tobaiqy, PhD, MSc, et al.
Published: (2020)

Rare lymphomatoid reactions following SARS-CoV-2 vaccination
by: Tessa LeWitt, BS, et al.
Published: (2022)